Prof. Joshua Krieger from Harvard Business School shares his perspectives on some of the challenges and opportunities in commercialization of diagnostic tests and gives us a preview of his business case study on Genomic Health.For more information, please visit https://www.NextGenerationDx.com/Commercialization-Molecular-Diagnostics